KRT`ye cevap verenler, cevap vermeyenler ve iyi cevap verenler
Transcription
KRT`ye cevap verenler, cevap vermeyenler ve iyi cevap verenler
Dr. Sabri DEMİRCAN Ondokuz Mayıs Üniversitesi Kardiyoloji Anabilim Dalı, Samsun ¡ ¡ KRT, ventriküler dissenkroninin elektrokardiyografik kanıtlarının olduğu orta ve ciddi kalp yetersizliği olan hastalarda semptom, hastaneye yatış ve mortaliteyi azaltmada etkisi gösterilmiş önemli bir tedavi seçeneğidir. KRT yapılan hastaların önemli bir çoğunluğu bu yöntemden fayda görmekle birlikte, % 30 – 40 hasta ya hiç fayda görmemekte ya da çok az fayda görmektedir. Cleland JG, et al. N Engl J Med 2005;352: 1539 – 49. § Optimal medikal tedaviye rağmen semptomatik § Orta – ileri (NYHA sınıf II -‐ IV) kalp yetersizliği § QRS ≥ 130 msn (Sol dal bloğu) § LVEF ≤ 35% § Normal sinüs ritm KRT–P / KRT-‐D morbidite ve mortaliteyi azaltmak için önerilir (Sınıf I / A) Eur Heart J 2012, May 19. ¡ 6 aylık takipte sistol sonu volümde % 15’den fazla azalma ¡ Klinik düzelme § Kardiyovasküler ölüm veya kalp yetersizliğine bağlı hastaneye yatış Chung ES, et al. Circulation 2008; 117: 2608 – 2616. 4 ¡ Cevap verenler (responder) ¡ Cevap vermeyenler (non-‐responder) ¡ İyi cevap verenler (hiper / super – responder) Chung ES, et al. Circulation 2008; 117: 2608 – 2616. 5 ¡ Tedavi sonrası kalpte dramatik düzelme olması (normalleşmesi) ¡ Özellikle noniskemik dilate KMP hastalarında tanımlanmış (% 20) ¡ Bu normalleşme kalıcı ya da takipte hastalık progresyonuyla birlikte geçici olabilir. ¡ Uzun dönem prognoz oldukça iyidir. Castellant P, et al. Heart Rhythm 2008;5:193–197. Castellant P, et al. Ann Noninvasive Electrocardiol 2010;15(4):321–327 6 ¡ ¡ Elektrokardiyografi Ekokardiyografi § M-‐mod § TDI ¡ Gated SPECT ¡ Geniş QRS kompleksli hastaların (≥120 ms) 1/3’ünde elektriksel dissenkroni göstergesi olarak mekanik dissenkroni tespit edilememektedir. ¡ Buna karşın dar QRS kompeksine (<120 ms) sahip hastaların ise yaklaşık %40-‐50’sinde mekanik dissenkroni vardır. Yu CM, et al. Heart 2003;89:54—60. ascular mortality. resynchronization therapy is now recommended in II HF.16 Cleland JGF. Eur J Heart Fail 2011;13,460–465 ("96% on ACE inhibitors or ARBs, "93% on bet 64% on ARAs), and therefore could not be impr The HTM programme included daily monitoring of and body weight and a simple electrocardiogram. Pa ¡ ¡ MADIT-‐CRT 1817 hastanın § % 70’inde LBBB § % 13’ünde RBBB § % 17’sinde nonspesifik ileti gecikmesi ¡ ¡ ¡ LBBB olan hastalarda KRT yapılmasının primer son nokta için HR 0.47 (95% CI 0.37-‐0.61) LBBB olmayan hastalarda ise HR 1.24 (95% CI 0.85-‐1.81) Çalışmanın tamamında LBBB olan hastaların kalp yetersizliğine bağlı olaylarda tedaviden faydası daha belirgin Zareba W. Circulation 2011; 123:1061-‐1072. § Optimal medikal tedaviye rağmen semptomatik § Orta – ileri (NYHA sınıf II -‐ IV) kalp yetersizliği § QRS ≥ 150 msn (Sol dal bloğu dışı) § LVEF ≤ 35% § Normal sinüs ritm KRT–P / KRT-‐D morbidite ve mortaliteyi azaltmak için önerilir (Sınıf IIa / A) Eur Heart J 2012, May 19. cardiography to Predict CRT Responders Table 1. Dyssynchrony Parameters and Cut-Off Values to Predict CRT Responders Dyssynchrony location Parameter Cutoff value Intraventricular SPWMD: the shortest interval between the maximal posterior displacement of the septum and the maximal displacement of the left posterior wall. Anatomical M-mode imaging should not be used to measure SPWMD. >130 ms Intraventricular 12Ts-SD: standard deviation of time from QRS to the largest peak systolic velocity in ejection phase for 12 LV segments. >34.4 ms Intraventricular Ts (lateral-septal): delay between time to the largest peak systolic velocity in ejection phase at basal septal and lateral segments. >65 ms Interventricular LV-PEP defined as the duration from onset of QRS to onset of pulsed Doppler LV out flow. >140 ms Interventricular IMD defined as the difference between LV-PEP and RV-PEP. IMD = LV-PEP – RV-PEP >40 ms Intra- and interventricular Sum of asynchrony: sum of LV asynchrony and LV-RV asynchrony measured by the time from QRS to regional onset of contraction (EMCT) with tissue pulsed Doppler. LV asynchrony; the difference between the maximum and the minimum EMCT in LV basal lateral, septal, and posterior wall. LV-RV asynchrony; the difference between the EMCT in the RV free wall and the maximum EMCT in LV basal lateral, septal, and posterior wall. >102 ms Atrioventricular DFT/RR: LV diastolic filling time measured by Doppler transmitral flow to cardiac cycle length. <40% CRT, cardiac resynchronization therapy; SPWMD, septal-to-posterior wall motion delay; LV, left ventricular; PEP, preSeo Yperiod; , et al. Circ J 2011; 75: mechanical 1156 – 1delay; 163 RV, right ventricular; EMCT, electromechanical coupling time. ejection IMD, interventricular Dyssynchrony estimation by nuclear imaging 1733 w Figure 1 Nakamura The main window processing the electrocardiogram-gated K, ofecardioGRAF t al. Europace (2011) 13, 1731–1737 myocardial perfusion single photon emission computed 1735 Dyssynchrony estimation by nuclear imaging w Downloaded from http://europace.oxfordjournals.org/ at Ondokuz Mayis Uni Figure 2 Changes in the time – volume curves derived by cardioGRAF analyses between temporary cardiac resynchronization therapy Nakamura K, et al. Europace (2011) 13, 1731–1737 suspension (CRT-off) and subsequent cardiac resynchronization therapy resumption (CRT-on) in a non-responder (A) or a responder (B) ¡ Stress Ekokardiyografi ¡ Gated SPECT ¡ MRI ¡ Sol ventrikül dissenkronisi ¡ Mitral regürgitasyon ¡ Kontraktil rezerv ¡ ¡ Çok merkezli, randomize, gözlem çalışması Dobutamin stress EKO ile kontraktil rezerv (% 5’den fazla artma) görülmesinin klinik ve ekokardiyografik yanıta (LESV’de % 10’dan fazla artış) etkisi Gasparini M, et el. Am Heart J 2012;163:422-‐9. American Heart Journal Volume 163, Number 3 Gasparini et al 425 Table II. Multivariable analysis for identification of independent predictors of response to CRT Univariable analysis Predictors of clinical response Inter-V dyssynchrony presence LVCR presence Predictors of echocardiographic response Inter-V dyssynchrony presence LVCR presence HR P 2.88 2.25 .009 .029 1.30 1.09 3.47 5.61 .001 b.001 1.61 3.06 .036). The DSE test showed 83% sensitivity and 88% positive predictive value. Specificity and negative predictive values were 33% and 25%, respectively. Multivariable Cox regression identified LVCR presence and inter-V dyssynchrony presence as independent predictors of response to resynchronization (HRs 2.25 and Gasparini M, et el. Am Heart J 2012;163:422-‐9. 2.88, respectively) (Table II). Multivariable analysis 95% CI HR P 95% CI 6.41 4.66 3.04 2.44 .007 .017 1.36 1.17 6.78 5.07 7.48 10.26 5.11 8.00 b.001 b.001 2.32 4.18 11.27 15.30 Figure 3 shows the positive predictive value of the different combinations of LVCR and inter-V dyssynchrony presence. Interestingly, the concomitant presence of both LVCR and inter-V dyssynchrony permitted to identify 99% of echo responders. Conversely, the concomitant absence of those 2 conditions was associated to the lack of echocardiographic response to CRT in 83% of patients. 7/*3.$"(8*23%4.$(9&2#( :;<:=(<:>(<?:@A< !"#$%&'&(&)(*$+ ,&'-./'%0&/&''().(1*23%*1(2&'4/152./%6*)%./ 2400 1 MV no MV % of pts in III-IV NYHA class NT-proBNP, pmol/L 1800 1600 0.8 0.7 0.6 0.5 1400 0.4 1200 0.3 before CRT 1 week 3 months no MV 0.9 2200 2000 MV 6 months before CRT a: NT-proBNP blood levels 1 week 3 months 6 months b: NYHA class 155 MV MV 15 no MV no MV % reduction of LVVs 150 LVVs, cm3 145 140 135 10 5 130 125 0 before CRT 1 week 3 months c: LVVs 6 months 1 week d: RR Figure 1. a: NT-proBNP levels. Time effect: p<0.0001; group effect: p=0.02; group-time effect: p=0.1 Pugliese M, et al. Anadolu Kardiyol erg 2012; 1effect: 2: 1p=0.009 32-‐41. b: NYHA class. Time effect: p<0.0001; groupD effect: p=0.003; group-time st 3 months 6 months 137 JACC: CARDIOVASCULAR IMAGING © 2008 BY THE AMERICAN COLLEGE OF CARDIOLOGY FOUNDATION PUBLISHED BY ELSEVIER INC. VOL. 1, NO. 5, 2008 ISSN 1936-878X/08/$34.00 DOI:10.1016/j.jcmg.2008.04.013 CLINICAL RESEARCH Cardiac Magnetic Resonance Assessment of Dyssynchrony and Myocardial Scar Predicts Function Class Improvement Following Cardiac Resynchronization Therapy Kenneth C. Bilchick, MD,* Veronica Dimaano, MD,* Katherine C. Wu, MD,* Robert H. Helm, MD,* Robert G. Weiss, MD,* Joao A. Lima, MD,* Ronald D. Berger, MD, PHD,* Gordon F. Tomaselli, MD, FAHA, FACC, FHRS,* David A. Bluemke, MD, PHD, FAHA,§ Henry R. Halperin, MD, FAHA,*†§ Theodore Abraham, MBBS, MD, * David A. Kass, MD, FAHA,*†‡ Albert C. Lardo, PHD, FACC, FAHA*†‡ Baltimore, Maryland O B J E C T I V E S We tested a circumferential mechanical dyssynchrony index (circumferential uniformity ratio estimate [CURE]; 0 to 1, 1 ! synchrony) derived from magnetic resonance-myocardial tagging (MR-MT) Bilchick KC, et al. clinical J Am function Coll Cardiol Img 2008;1:561–8 for predicting class improvement following cardiac resynchronization therapy (CRT). peaks in the septal or lateral walls. : CARDIOVASCULAR IMAGING, VOL. 1, NO. 5, 2008 EMBER 2008:561– 8 Bilchick et al. MR-MT Circumferential Dyssynchrony and CRT Efficacy DISCUSSION 567 Main findings. This is the first published series normal subjects) is consistent with recent data from the RETHINQ (Resynchronization Therapy in Patients with Narrow QRS) study, in which TDI failed to identify narrow QRS patients who would benefit from CRT (24). evaluating MR-MT assessment of circumferential Table 2.findings MR-MT andcontext DE-CMR for CRT Response Present in the of prior CMR dyssynchrony studies. This is the first study to support the use of MR-MT circumferential strain for CRT selection Sensitivity PPV NPV Accuracy based on long-term function class improvement. Specificity Other MR protocols such as radial motion analysis (25) and % CMR total longitudinal scar !15%* 91 57 77 80 78 phase velocity have essentially mimicked TDI by determining longitudinal timing71 MR-MT CURE !0.75* radial or100 87 100 90 delays and have not been shown to identify CRT Both present* 100 93 100 95 responders. Of note, the usefulness of MR-MT circum-86 ferential strain for dyssynchrony had been suggested by *Allprior numbers reported are percentages. small acute hemodynamic studies of left ventricular CRT " cardiac resynchronization therapy; CURE " circumferential uniformity ratio estimate; or biventricular pacing (9,26). DE-CMR " delayed magnetic CRT selection. Weenhancement-cardiac have shown that MR-MT assess-resonance; MR-MT " magnetic resonancemyocardial tagging; NPV " negative predictive value; PPV " positive predictive value. ment of mechanical dyssynchrony has excellent predictive accuracy for improvement in function class after CRT and may be enhanced by DE-CMR scar imaging. CURE: Circumferential uniformity ratio estimate (dissenkroni indeksi) These findings highlight the unique value of MR-MT/ DE-CMR to characterize both mechanical function and scar extent/distribution in CRT candidates prior to implantation. Study limitations. There are several limitations to the ure 5. CRT Nonresponse Due to Extensive Scar study. Due to the retrospective nature of the assessment r imaging from a subject with significant circumferential dyssynof clinical response, routine post-CRT echocardio- Bilchick KC, et al. J Am Coll Cardiol Img 2008;1:561–8 ony but CRT nonresponse shows extensive left ventricular scar Among the 87 patients with DCM, 10 (12%) demonstrated a reduction of one or more NYHA functional class, an increase in the LVEF to two-fold or more the baseline LVEF or to an absolute value .45%, and a decrease in the LVESV .15%, 6 months after CRT. These patients, who had no re-hospitalizations for the management of congestive heart failure, were considered superresponders to CRT. In 34 patients (38.4%), the LVESV did not reduce or had a reduction ,15% after CRT (non-responders). responder group (Table 2). Regarding the magnitude of response, LV volumes, LVEF, and LVESD showed a significantly greater improvement in super-responders than in the other patients (Figure 1). The variation of NYHA functional class, intraventricular dyssynchrony and IVD, and mitral regurgitation JA was not significantly different between the two groups. There were no re-admissions for heart failure 6 months after CRT in the super-responder group and a re-admission rate of Table 1 Comparison of baseline characteristics of super-responders and the other patients Super-responders (n 5 10) Other patients (n 5 77) P-value Male gender (%) 60 64 0.54 ICM (%) Age (years) 50 60 + 8 34 62 + 11 0.32 0.41 NYHA class 3.0 + 0.7 3.1 + 0.6 0.66 Duration of symptoms (months) QRS duration (ms) 15.1 + 17.8 153.5 + 30.8 33.9 + 35.7 143.5 + 31.6 0.01 0.30 JA (cm2) 5.4 + 6.7 8.1 + 5.4 0.04 LVEDD (mm) LVESD (mm) 69.3 + 6.4 57.3 + 7.5 75.3 + 10.0 63.6 + 10.2 0.04 0.06 LVEDV (mL) 244.4 + 72.8 267.9 + 110.4 0.60 LVESV (mL) Sphericity index 192.8 + 72.3 0.62 + 0.11 204.8 + 94.0 0.66 + 0.16 0.79 0.48 LVEF (%) 22.5 + 8.6 24.4 + 6.5 0.43 LV dP/dt (mmHg/s) Intraventricular dyssynchrony (ms) 515.8 + 247.4 113.0 + 96.7 476.3 + 160.5 78.8 + 40.2 0.89 0.37 Interventricular dyssynchrony (ms) 57.0 + 35.6 49.1 + 23.4 0.35 ............................................................................................................................................................................... ICM, ischaemic cardiomyopathy; JA, mitral regurgitation jet area; LVEDD, left ventricular end-diastolic diameter; LVESD, left ventricular end-systolic diameter; LVEDV, left ventricular end-diastolic volume; LVESV, left ventricular end-systolic volume; LVEF, left ventricular ejection fraction. Antonio N, et al. Europace (2009) 11, 343–349 N. An e 3 Multivariate logistic regression analysis for predictors of super-response to cardiac resynchronization therapy. 3 Comparison of effects of cardiac hronization therapy in patients in New York Antonio (NYHA) N, et al. class Europace 11, in343–349 Association II with(2009) patients cardiomyopathy when the probability of complete reve delling is higher. Finally, this is the first report of super-r in off-label indications to CRT. Figure 1 Percentage of responders, according to the extent of reduction in left ventricular end-systolic volume (A) and the combination of clinical response and a reduction in left ventricular end-systolic volume !15% (B). Table 3 Differences in baseline characteristics between super-responders, responders, non-responders, and negative responders SUPER (n 5 108) RESP (n 5 53) NON (n 5 67) NEG (n 5 58) P-value Age, years Gender, male, n (%) 68 + 10 63 (58) 67 + 10 43 (81) 68 + 11 49 (73) 66 + 13 47 (81) 0.37 0.0026 NYHA class IV, n (%) 1 (1) 2 (4) 3 (4) 5 (9) 0.016 Non-ischaemic aetiology, n (%) Diabetes, n (%) 60 (56) 27 (25) 25 (47) 16 (30) 27 (40) 22 (33) 23 (40) 16 (28) 0.023 0.52 History of AF, n (%) 21 (19) 11 (21) 10 (15) 11 (19) 0.71 History of VT, n (%) QRS duration, ms 19 (18) 166 + 20 13 (25) 168 + 26 25 (37) 163 + 23 23 (40) 158 + 24 0.0005 0.033 LVEF, % 30 + 9 27 + 8 29 + 11 29 + 10 0.73 LVESV, mL LVEDV, mL 161 + 88 223 + 102 196 + 81 261 + 93 168 + 90 230 + 97 167 + 89 229 + 100 0.77 0.83 LVFT/RR, % 43 + 9 43 + 8 46 + 8 45 + 10 0.051 IVMD, ms Ts-(lateral-septal), ms 50 + 35 68 + 44 47 + 34 50 + 38 44 + 38 49 + 38 25 + 39 44 + 35 0.0002 0.0022 ............................................................................................................................................................................... Abbreviations as in Table 2. SUPER, super-responders; RESP, responders; NON, non-responders; NEG, negative responders. Provided P-values are for trend between subgroups, Cochran –Mantel –Haenszel test for categorical variables, and least squares regression for continuous variables. Significant P-values in boldface. Chung ES. Circulation 2008;117:2608–2616 ¡ Uygun endikasyon ¡ Uygun implantasyon ¡ Dissenkroninin varlığı ve derecesi ¡ Etyoloji ¡ Hastalık süresi ¡ Hastalık ciddiyeti ¡ Skar boyutu 25